CTVA vs FNV

Corteva (CTVA) trades at a premium valuation with mixed profitability trends and strong recent earnings surprises, though near-term earnings growth remains challenged. The stock has underperformed over the past six months (-3.3%) despite solid 1-year and 5-year returns (+16.1%, +85.9%), reflecting macro pressures in agricultural inputs. While revenue growth of 12.6% outpaces the sector average of 6.16%, negative operating margins (-10.31%) and volatile quarterly EPS performance raise concerns about execution and cost structure. Analysts are constructive with a $77.71 target implying 17.7% upside, but recent insider selling adds caution, offsetting an otherwise healthy balance sheet and sustainable dividend policy.

Franco-Nevada exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a massive current ratio of 8.30, indicating a fortress balance sheet. While the stock trades at a significant premium to its Graham Number ($71.7) and Intrinsic Value ($170.21), this is supported by explosive YoY revenue growth of 85.8% and earnings growth of 108.8%. The company's royalty-based model is reflected in its extraordinary profit margins (61.64%), though current technical trends are bearish. Long-term value is driven by consistent earnings beats and a strong analyst target of $306.36. Price trades at a 28.6% premium to fair value estimate ($188.50), limiting near-term upside from a valuation perspective.